Charter Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Charter Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Sell	4,211 -250	-6%	-$14.4K	0.11%	63
2026 Q1	$271K	Hold	4,461	–	–	0.14%	56
2025 Q4	$241K	Hold	4,461	–	–	0.12%	59
2025 Q3	$201K	Sell	4,461 -540	-11%	-$25.2K	0.11%	60
2025 Q2	$231K	Buy	+5,001	New	+$245K	0.14%	59

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Charter Capital Management's BMY Position: Q2 2026 in Review

Charter Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q2 2026, selling an estimated $14.4K and leaving 4,211 shares worth $243K. The position accounts for 0.11% of the portfolio, ranked #63.

Charter Capital Management first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $271K in Q1 2026. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Charter Capital Management held 4,211 shares of Bristol-Myers Squibb worth $243K as of Q2 2026.
Charter Capital Management sold 250 Bristol-Myers Squibb shares in Q2 2026, an estimated $14.4K.
Bristol-Myers Squibb made up 0.11% of Charter Capital Management's portfolio in Q2 2026, its #63 holding.
Charter Capital Management first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
Charter Capital Management's Bristol-Myers Squibb position peaked at $271K in Q1 2026.
832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Charter Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.